Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00476970 · ClinicalTrials.gov registry record · NA

Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
1,223
Enrollment target

NCT00476970: Completed NA study, sponsored by Massachusetts General Hospital.

NCT00476970 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 1,223 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00476970, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
1,223 participants
Enrollment target

Study Summary

The goal of this study is to implement and in a controlled randomised trial test a program to identify and overcome barriers to CRC screening and thus improve CRC screening rates at MGH Chelsea HC. Our hypothesis is that a bilingual navigator program, enhanced by using trained interpreting staff will improve CRC screening rates at MGH Chelsea HC overall, and decrease disparities between patients with limited English proficiency and English speakers

Interventions

  • BEHAVIORAL Patient Navigation

Trial Details

FieldValue
Enrollment Target 1,223 participants
Start Date 2007-09
Est. Completion 2008-09
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT00476970

The ClinicalTrials.gov registry entry for NCT00476970 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Patient Navigation is the first listed.

NCT00476970 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00476970 about?

NCT00476970 is a clinical study titled "Colorectal Cancer Screening Navigator Program for Low Income and Non-English Speaking Populations". The goal of this study is to implement and in a controlled randomised trial test a program to identify and overcome barriers to CRC screening and thus improve CRC screening rates at MGH Chelsea HC. Our hypothesis is that a bilingual navigator program, enhanced by using trained interpreting staff wi...

What is the current status of trial NCT00476970?

This trial is currently completed. It is a NA study. The enrollment target is 1,223 participants. The study started on 2007-09. Estimated completion is 2008-09.

What interventions are being tested in trial NCT00476970?

The interventions under investigation include: Patient Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT00476970?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.